Dear Investigator,
To address the opioid crisis, NIH has developed the NIH HEAL (Helping to End Addiction Long-term) Initiative. The following funding opportunity announcement.
Table of contents:
I. TA Webinar for NIDA HEAL Prevention Funding Opportunities: January 17, 2019 12:30 - 2:00 p.m. - Please register and save the date
II. HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed) (RFA-HL-19-028)
III.HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional) (RFA-HL-19-029)
IV. For Information about other HEAL (Helping to End Addiction Long-termS Initiative) please click here.
-----------------
I.TA Webinar for NIDA HEAL Prevention Funding Opportunities: January 17, 2019 12:30 - 2:00 p.m. - Please register and save the date
A technical assistance webinar is scheduled to assist potential applicants to the following prevention specific HEAL initiatives:
And
The intent of this pre-application webinar is to provide an overview of the HEAL Prevention FOAs and to address general questions from potential applicants.
Attendees are encouraged to register for the webinar in advance. The webinar is optional and not required for application submission. The webinar may conclude before the scheduled time depending on the number of questions.
Following the webinar, NIDA will post the slides that are presented. Prospective applicants with inquiries concerning the FOAs who are unable to participate in the Webinar are encouraged to view the summary of questions and answers after the Webinar.
Webinar Information
Date: January 17, 2019
Time: 12:30 - 2:00 pm EST
Event address for attendees (to register and attendhttps://nih.webex.com/nih/onstage/g.php?MTID=e377439f43efc0136f1c75ecb8938b880):
FOAs to be discussed
Please click on the links below to see the full announcements and instructions.
HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16–30) Initiative (U24 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-034.html
HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16–30) (UG3/UH3 Clinical Trial Required)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-035.html
Please share this information within your networks and widely.
For more information contact:
Jacqueline Lloyd, PhD, MSW
Deputy Branch Chief
Prevention Research Branch
Division of Epidemiology, Services and Prevention Research
National Institute on Drug Abuse
National Institutes of Health
US Department of Health and Human Services
6001 Executive Blvd. Room 5173
Bethesda, MD 20892-9589
Email: lloydj2@nida.nih.gov
Phone: 301-443-8892
Fax: 301-443-2636
II. HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed) (RFA-HL-19-028)
Application due date: February 27, 2019
This FOA invites applications that propose to elucidate basic sleep and circadian mechanisms closely-coupled to the risk of opiate use disorder (OUD), the pathobiology of opiate withdrawal, and that influence the response to medication-assisted treatment (MAT). Studies are needed to apply advances in understanding sleep and circadian biology to improving our understanding of OUD, the directionality of sleep and OUD interactions, and the opportunities to improve therapy and outcome. Multi-disciplinary, multiple-investigator teams combining expertise in sleep and circadian neurobiology with the neurobiology OUD and pharmacology of MAT are strongly encouraged. This FOA is only open to the study of OUD relevant mechanisms and pathobiology. The study of other drugs of abuse will not be responsive.
See RFA-HL-19-028 for complete details.
Correspondence should be directed to”
Aaron D. Laposky, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-7837
Email: laposkya@nhlbi.nih.gov
Steve Grant, PhD
National Institute on Drug Abuse (NIDA)
Telephone: (301) 443-8869
Email: sgrant@nida.nih.gov
III. HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional) (RFA-HL-19-029)
Application due date: February 27, 2019
his FOA invites applications for human subjects research to elucidate sleep/circadian mechanisms closely-coupled to the risk of opiate use disorder (OUD), the pathobiology of opiate withdrawal, and the response to medication-assisted treatment (MAT). Identifying sleep/circadian mechanisms and determining the directionality of sleep and OUD interactions addresses a knowledge gap and new opportunities for improved therapy and outcome. Multi-disciplinary, multiple-investigator teams of researchers combining expertise in clinical research and mechanisms of sleep/circadian science and OUD/MAT are strongly encouraged. Clinical trials focused on mechanistic endpoints and/or understanding how an intervention works may be proposed. This FOA is only open to the study of OUD relevant mechanisms and pathobiology. The study of other drugs of abuse or efficacy focused trials will not be responsive.
See RFA-HL-19-029 for complete details.
Correspondence should be directed to:
Aaron D. Laposky, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: (301) 827-7837
Email: laposkya@mail.nih.gov
Steve Grant, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-8869
Email:sgrant@nida.nih.gov
IV . For Information about other HEAL (Helping to End Addiction Long-termS Initiative) please click here.
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
No comments:
Post a Comment